Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (Q3)Dec 31, 2025 | (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 79.24%3.3M | -429.47%-638.44K | 187.68%2.15M | -27.83%4.26M | 4.99M | 1.84M | -120.58K | -2.45M | -41.54%5.9M | 351.58%10.1M |
| Net profit before non-cash adjustment | 124.78%3.19M | 106.79%168.53K | -19.89%1.1M | -69.51%2.42M | --2.11M | --1.42M | ---2.48M | --1.37M | -0.84%7.94M | 87.85%8M |
| Total adjustment of non-cash items | -301.94%-234.29K | 21.69%185.48K | -79.43%46.98K | 876.68%556.2K | --59.35K | --116.02K | --152.43K | --228.4K | -114.96%-71.61K | -29.73%478.72K |
| -Depreciation and amortization | 13.04%280.65K | 2.59%248.53K | 5.30%259.28K | 9.18%979.88K | --243.12K | --248.27K | --242.24K | --246.24K | 9.82%897.52K | -1.92%817.24K |
| -Reversal of impairment losses recognized in profit and loss | ---1.99K | 11.98%1.99K | -99.95%2 | 1,174.49%15.04K | --9.6K | --0 | --1.78K | --3.66K | -91.87%1.18K | 2.93%14.51K |
| -Disposal profit | -1,808.81%-362.93K | --93K | ---60K | 96.87%-21.24K | ---42.48K | --21.24K | --0 | --0 | -285.53%-678.52K | -83.75%-176K |
| -Other non-cash items | 2.27%-150.01K | -72.54%-158.03K | -608.41%-152.31K | -43.07%-417.48K | ---150.89K | ---153.5K | ---91.59K | ---21.5K | -64.82%-291.8K | -151.98%-177.04K |
| Changes in working capital | 11.91%340.9K | -144.91%-992.45K | 124.72%1M | 165.45%1.28M | --2.82M | --304.61K | --2.21M | ---4.05M | -221.58%-1.96M | 159.64%1.61M |
| -Change in receivables | 23.81%633.64K | -183.33%-544.04K | 325.98%466.55K | 124.32%570.36K | ---703.84K | --511.77K | --652.9K | --109.52K | -253.10%-2.35M | 156.43%1.53M |
| -Change in inventory | 350.38%167.6K | -100.31%-3.21K | 107.62%60.12K | -71.50%-303.4K | ---592.53K | --37.21K | --1.04M | ---788.9K | -130.41%-176.91K | 183.49%581.67K |
| -Change in payables | -88.37%-460.33K | -186.23%-445.2K | 114.06%473.53K | 81.73%1.02M | --4.11M | ---244.37K | --516.29K | ---3.37M | 212.10%559.92K | -170.84%-499.5K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -93.49%-1.69K | -60.62%-1.77K | -40.88%-2.05K | 30.17%-4.18K | -752 | -875 | -1.1K | -1.45K | 33.87%-5.99K | 39.22%-9.06K |
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | -848.32%-695.42K | -91.78%7.8K | -0.60%-281.92K | 10.86%-1.48M | -1.22M | -73.33K | 94.91K | -280.25K | 0.84%-1.66M | -80.05%-1.67M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 47.33%2.6M | -2,261.94%-632.41K | 168.22%1.86M | -34.44%2.78M | --3.77M | --1.77M | ---26.78K | ---2.73M | -49.55%4.25M | 550.78%8.42M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -59.09%-2.21M | 250.89%488.05K | -391.17%-1.29M | 8.83%-6.9M | ---4.93M | ---1.39M | ---323.45K | ---263.13K | -1,403.46%-7.57M | -1,001.34%-503.38K |
| Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --30K | ---- |
| Interest received (cash flow from investment activities) | -1.73%151.7K | 72.39%159.8K | 572.49%154.36K | 41.69%421.1K | --151.08K | --154.37K | --92.7K | --22.95K | 59.70%297.21K | 118.52%186.1K |
| Net changes in other investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%30K | ---30K |
| Investing cash flow | -88.91%-2.06M | 272.41%647.85K | -373.84%-1.14M | 10.52%-6.48M | ---4.77M | ---1.09M | ---375.75K | ---240.17K | -1,985.04%-7.24M | -346.28%-347.28K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Net common stock issuance | --0 | ---- | ---- | 17,819,900.00%17.82M | --0 | --0 | ---- | ---- | --100 | --0 |
| Increase or decrease of lease financing | 52.05%-5.35K | 110.82%1.31K | -91.03%-26.45K | 64.99%-48.22K | ---11.09K | ---11.16K | ---12.12K | ---13.85K | 15.85%-137.71K | -4.03%-163.64K |
| Issuance fees | --0 | ---- | ---- | ---1.13M | --100.16K | --0 | ---- | ---- | --0 | ---- |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.66%-3M | -15,000.00%-3.02M |
| Interest paid (cash flow from financing activities) | ---- | ---- | ---- | 30.16%-4.18K | ---- | ---- | ---- | ---- | ---5.99K | ---- |
| Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 6,680.57%1.32M | -12.65%-20.07K |
| Financing cash flow | 52.05%-5.35K | -99.99%1.31K | -91.03%-26.45K | 1,012.42%16.63M | --84.89K | ---11.16K | --16.57M | ---13.85K | 43.09%-1.82M | -1,541.99%-3.2M |
| Net cash flow | ||||||||||
| Beginning cash position | 2.32%20.49M | 430.80%20.48M | 189.15%19.78M | -41.32%6.84M | --20.7M | --20.03M | --3.86M | --6.84M | 71.69%11.66M | 22.33%6.79M |
| Current changes in cash | -18.80%542.28K | -99.90%16.76K | 123.38%697.27K | 368.64%12.94M | ---917.04K | --667.84K | --16.17M | ---2.98M | -198.96%-4.82M | 292.70%4.87M |
| End cash Position | 1.64%21.04M | 2.32%20.49M | 430.80%20.48M | 189.15%19.78M | --19.78M | --20.7M | --20.03M | --3.86M | -41.32%6.84M | 71.69%11.66M |
| Free cash flow | -47.30%187.93K | 66.49%-117.36K | 117.02%509.37K | -2.83%-4.14M | ---1.15M | --356.63K | ---350.22K | ---2.99M | -152.00%-4.02M | 519.15%7.74M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.